Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
4,330
datasets available to search
ShareScore release 0.9.0
Dataset results
4,330 results for “Melanoma”
Comparison of Ipilimumab Manufactured by 2 Different Processes in Participants With Advanced Melanoma
ClinicalTrials.gov study NCT00920907. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk Melanoma
ClinicalTrials.gov study NCT03698019. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Study to Test the Benefit of a New Anti-cancer Treatment in Patients With Unresectable Advanced Melanoma
ClinicalTrials.gov study NCT00942162. IPD Sharing: YES. Countries: 8. Publications: 1.
Study of Gene Modified Immune Cells in Patients With Advanced Melanoma
ClinicalTrials.gov study NCT00910650. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Phase 2 Study of Ipilimumab Plus Dacarbazine in Japanese Patients With Advanced Melanoma
ClinicalTrials.gov study NCT01681212. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Efficacy of Pembrolizumab Compared to Placebo in Resected High-risk Stage II Melanoma (MK-3475-716/KEYNOTE-716)
ClinicalTrials.gov study NCT03553836. IPD Sharing: YES. Countries: 16. Publications: 8.
Treatment of Resistant Metastatic Melanoma Using Decitabine, Temozolomide and Panobinostat
ClinicalTrials.gov study NCT00925132. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of Imprime PGG and Pembrolizumab in Advanced Melanoma and Triple Negative Breast Cancer
ClinicalTrials.gov study NCT02981303. IPD Sharing: NO. Countries: 1. Publications: 2.
Nivolumab Combined With Ipilimumab Followed by Nivolumab Monotherapy as First-Line Treatment for Patients With Advanced Melanoma
ClinicalTrials.gov study NCT02599402. IPD Sharing: Not stated. Countries: 12. Publications: 1.
Pixatimod (PG545) Plus Nivolumab in PD-1 Relapsed/Refractory Metastatic Melanoma and NSCLC and With Nivolumab and Low-dose Cyclophosphamide in MSS Metastatic Colorectal Carcinoma (mCRC)
ClinicalTrials.gov study NCT05061017. IPD Sharing: NO. Countries: 1. Publications: 1.
Study CB-839 in Combination With Nivolumab in Patients With Melanoma, Clear Cell Renal Cell Carcinoma (ccRCC) and Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT02771626. IPD Sharing: NO. Countries: 1. Publications: 1.
Dabrafenib Alone and in Combination With Trametinib Before Surgery in Treating Patients With Locally or Regionally Advanced Melanoma That Can Be Removed By Surgery
ClinicalTrials.gov study NCT01701037. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Onalespib, Dabrafenib, and Trametinib in Treating Patients With BRAF-Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
ClinicalTrials.gov study NCT02097225. IPD Sharing: Not stated. Countries: 1. Publications: 1.
CAVATAK in Patients With Stage IIIc or IV Malignant Melanoma to Extend Dosing to 48 Weeks (VLA-008 CALM Ext)
ClinicalTrials.gov study NCT01636882. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma
ClinicalTrials.gov study NCT03635983. IPD Sharing: Not stated. Countries: 27. Publications: 2.
A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma
ClinicalTrials.gov study NCT01584648. IPD Sharing: Not stated. Countries: 14. Publications: 8.
Patient-led Surveillance Compared to Clinician-led Surveillance in People Treated for Localised Melanoma.
ClinicalTrials.gov study NCT03581188. IPD Sharing: NO. Countries: 1. Publications: 1.
Phase II Trial of Ontak With Metastatic Melanoma
ClinicalTrials.gov study NCT00299689. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Vorinostat in Treating Patients With Metastatic or Unresectable Melanoma
ClinicalTrials.gov study NCT00121225. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Immunization With the MAGE-3.A1 Peptide Mixed With the Adjuvant CpG 7909 in Patients With Metastatic Melanoma
ClinicalTrials.gov study NCT00145145. IPD Sharing: NO. Countries: 1. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.